Brown BG - Search Results

1

Secondary prevention of heart disease amongst patients with lipid abnormalities: practice and trends in the United States.

Brown BG, Zhao XQ, Bardsley J, Albers JJ. Brown BG, et al. J Intern Med. 1997 Apr;241(4):283-94. doi: 10.1046/j.1365-2796.1997.109132000.x. J Intern Med. 1997. PMID: 9159600 Free article. Review.

2

Arteriographic view of treatment to achieve regression of coronary atherosclerosis and to prevent plaque disruption and clinical cardiovascular events.

Brown BG, Zhao XQ, Sacco DE, Albers JJ. Brown BG, et al. Br Heart J. 1993 Jan;69(1 Suppl):S48-53. doi: 10.1136/hrt.69.1_suppl.s48. Br Heart J. 1993. PMID: 8427765 Free PMC article. Review.

3

Atherosclerosis regression, plaque disruption, and cardiovascular events: a rationale for lipid lowering in coronary artery disease.

Brown BG, Zhao XQ, Sacco DE, Albers JJ. Brown BG, et al. Annu Rev Med. 1993;44:365-76. doi: 10.1146/annurev.me.44.020193.002053. Annu Rev Med. 1993. PMID: 8476257 Review.

4

Lipid lowering and plaque regression. New insights into prevention of plaque disruption and clinical events in coronary disease.

Brown BG, Zhao XQ, Sacco DE, Albers JJ. Brown BG, et al. Circulation. 1993 Jun;87(6):1781-91. doi: 10.1161/01.cir.87.6.1781. Circulation. 1993. PMID: 8504494 Review.

5

Lipid altering or antioxidant vitamins for patients with coronary disease and very low HDL cholesterol? The HDL-Atherosclerosis Treatment Study Design.

Brown BG, Zhao XQ, Chait A, Frohlich J, Cheung M, Heise N, Dowdy A, DeAngelis D, Fisher LD, Albers J. Brown BG, et al. Can J Cardiol. 1998 Apr;14 Suppl A:6A-13A. Can J Cardiol. 1998. PMID: 9594927 Review.

6

Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease.

Brown BG, Zhao XQ, Chait A, Fisher LD, Cheung MC, Morse JS, Dowdy AA, Marino EK, Bolson EL, Alaupovic P, Frohlich J, Albers JJ. Brown BG, et al. N Engl J Med. 2001 Nov 29;345(22):1583-92. doi: 10.1056/NEJMoa011090. N Engl J Med. 2001. PMID: 11757504 Free article. Clinical Trial.

7

Effects of lowering elevated LDL cholesterol on the cardiovascular risk of lipoprotein(a).

Maher VM, Brown BG, Marcovina SM, Hillger LA, Zhao XQ, Albers JJ. Maher VM, et al. Among authors: brown bg. JAMA. 1995 Dec 13;274(22):1771-4. JAMA. 1995. PMID: 7500507 Clinical Trial.

8

Safety and tolerability of simvastatin plus niacin in patients with coronary artery disease and low high-density lipoprotein cholesterol (The HDL Atherosclerosis Treatment Study).

Zhao XQ, Morse JS, Dowdy AA, Heise N, DeAngelis D, Frohlich J, Chait A, Albers JJ, Brown BG. Zhao XQ, et al. Among authors: brown bg. Am J Cardiol. 2004 Feb 1;93(3):307-12. doi: 10.1016/j.amjcard.2003.10.009. Am J Cardiol. 2004. PMID: 14759379 Clinical Trial.

9

Is intravascular ultrasound the gold standard surrogate for clinically relevant atherosclerosis progression?

Brown BG, Zhao XQ. Brown BG, et al. J Am Coll Cardiol. 2007 Mar 6;49(9):933-8. doi: 10.1016/j.jacc.2006.12.014. Epub 2007 Feb 16. J Am Coll Cardiol. 2007. PMID: 17336715 Free article. Review.

10

Nicotinic acid, alone and in combinations, for reduction of cardiovascular risk.

Brown BG, Zhao XQ. Brown BG, et al. Am J Cardiol. 2008 Apr 17;101(8A):58B-62B. doi: 10.1016/j.amjcard.2008.02.039. Am J Cardiol. 2008. PMID: 18375243 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

197 results

Search Page

Filters